Eric I. Richman

Insider Reports History

Location
Potomac, MD
Signature
/s/ Eric I. Richman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric I. Richman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Gain Therapeutics, Inc. Director Common Stock 289,629 $1,117,678 $3.86 01 Jul 2024 Direct
Gain Therapeutics, Inc. Director Stock Option (right to buy) 15,000 $87,900 $5.86 24 Jun 2025 Direct
NeuBase Therapeutics, Inc. Director Common stock 44,960 $86,323 $1.92 04 Mar 2022 Direct
Gain Therapeutics, Inc. Director Common Stock 14,829 $57,225 $3.86 01 Jul 2024 By Trust
NeuBase Therapeutics, Inc. Director Common stock 27,747 $53,274 $1.92 01 Mar 2022 Indirect
NeuBase Therapeutics, Inc. Director Stock option (right to buy) 37,600 09 Sep 2022 Direct

Insider Reports Filed by Eric I. Richman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GANX Gain Therapeutics, Inc. 24 Jun 2025 1 $0 4 Director 25 Jun 2025, 17:30
GANX Gain Therapeutics, Inc. 01 Jul 2024 2 +$20,670 4 Director 01 Jul 2024, 17:00
GANX Gain Therapeutics, Inc. 24 Jun 2024 1 $0 4 Director 26 Jun 2024, 21:30
GANX Gain Therapeutics, Inc. 20 Sep 2023 2 $0 4 Director 22 Sep 2023, 17:34
GANX Gain Therapeutics, Inc. 20 Sep 2022 2 $0 4 Director 22 Sep 2022, 16:14
/report/000110465922099290-richman-eric-i-2022-09-09 NeuBase Therapeutics, Inc. 09 Sep 2022 1 $0 4 Director 12 Sep 2022, 17:01
GANX Gain Therapeutics, Inc. 25 May 2022 1 +$6,404 4 CHIEF EXECUTIVE OFFICER, Director 27 May 2022, 16:10
GANX Gain Therapeutics, Inc. 19 May 2022 2 +$37,034 4 CHIEF EXECUTIVE OFFICER, Director 23 May 2022, 16:41
/report/000110465922031172-richman-eric-i-2022-03-01 NeuBase Therapeutics, Inc. 01 Mar 2022 3 +$6,352 4 Director 07 Mar 2022, 18:13
/report/000110465921116920-richman-eric-i-2021-08-19 NeuBase Therapeutics, Inc. 19 Aug 2021 1 $0 4 Director 17 Sep 2021, 16:16
GANX Gain Therapeutics, Inc. 16 Aug 2021 1 +$38,716 4/A Chief Executive Officer, Director 21 Apr 2022, 16:50
GANX Gain Therapeutics, Inc. 17 Mar 2021 0 $0 3/A Chief Executive Officer, Director 21 Apr 2022, 16:47